SWK Holdings Co. (NASDAQ:SWKH - Get Free Report) shares shot up 0.4% on Wednesday . The stock traded as high as $16.25 and last traded at $15.85. 3,815 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 10,682 shares. The stock had previously closed at $15.79.
SWK Stock Up 0.4 %
The stock has a market cap of $193.85 million, a price-to-earnings ratio of 17.04 and a beta of 0.36. The company has a quick ratio of 5.06, a current ratio of 5.06 and a debt-to-equity ratio of 0.11. The stock has a fifty day moving average of $16.60 and a two-hundred day moving average of $16.93.
Institutional Trading of SWK
A number of institutional investors have recently modified their holdings of the company. Barclays PLC lifted its position in SWK by 185.0% during the third quarter. Barclays PLC now owns 4,461 shares of the company's stock valued at $77,000 after buying an additional 2,896 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in SWK in the 2nd quarter valued at $172,000. Dimensional Fund Advisors LP raised its position in SWK by 85.7% in the second quarter. Dimensional Fund Advisors LP now owns 30,109 shares of the company's stock valued at $511,000 after purchasing an additional 13,892 shares during the period. SkyView Investment Advisors LLC lifted its stake in shares of SWK by 7.7% during the second quarter. SkyView Investment Advisors LLC now owns 31,165 shares of the company's stock worth $529,000 after purchasing an additional 2,234 shares in the last quarter. Finally, Victory Capital Management Inc. purchased a new stake in shares of SWK in the third quarter worth about $589,000. Hedge funds and other institutional investors own 99.27% of the company's stock.
SWK Company Profile
(
Get Free Report)
SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.
Featured Stories
Before you consider SWK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SWK wasn't on the list.
While SWK currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
